CS
CUE icon

Credit Suisse’s Cue Biopharma CUE Stock Holding History

Credit Suisse’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 4080
2022
Q2 		$0 Sell
1
-734
-100% -$85.9K ﹤0.01% 3996
2022
Q1 		$108K Buy
735
+49
+7% +$10.4K ﹤0.01% 3466
2021
Q4 		$232K Buy
686
+153
+29% +$59.2K ﹤0.01% 4222
2021
Q3 		$233K Sell
533
-188
-26% -$65.6K ﹤0.01% 4178
2021
Q2 		$252K Sell
721
-44
-6% -$17.1K ﹤0.01% 4190
2021
Q1 		$280K Sell
765
-1,084
-59% -$446K ﹤0.01% 4020
2020
Q4 		$694K Sell
1,849
-105
-5% -$42K ﹤0.01% 3607
2020
Q3 		$882K Buy
1,954
+179
+10% +$103K ﹤0.01% 3032
2020
Q2 		$1.3M Buy
+1,775
New +$1.29M ﹤0.01% 2717

Other funds holding CUE

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse's CUE Position: Q3 2022 in Review

Credit Suisse sold out of Cue Biopharma (CUE) in Q3 2022, closing a stake of 1 share.

Credit Suisse first reported a position in CUE in Q2 2020 and held it in 9 quarters. The position peaked at $1.3M in Q2 2020. 64 funds tracked by Wall St. Rank hold CUE as of Q3 2022.

  • Credit Suisse reported no remaining Cue Biopharma position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 1 Cue Biopharma share in Q3 2022.
  • Credit Suisse first reported a position in Cue Biopharma in Q2 2020 and held it in 9 quarters.
  • Credit Suisse's Cue Biopharma position peaked at $1.3M in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.